The AMSA® manosonic nebulizer for ENT disease among children in Poland
Use of the AMSA manosonic nebulizer appears to be an effective way of improving chronic medical conditions in children - such as chronic otitis media with effusion and Eustachian tube defect - but only if patient compliance can be achieved. The most frequently used active substance was budesonide, irrespective of whether additional secretolic/mucolytic agent was administered.
Authors
- Milaine Dominici Sanfins (ORCID: https://orcid.org/0000-0002-3647-3999)
- Agata Szkiełkowska (ORCID: https://orcid.org/0000-0003-2122-7872)
- Piotr Henryk Skarzynski (ORCID: https://orcid.org/0000-0002-4978-1915)
- Magdalena Beata Skarzynska (ORCID: https://orcid.org/0000-0003-3340-1698)
- Elżbieta Gos (ORCID: https://orcid.org/0000-0003-3173-3867)
- Patryk Hartwich (ORCID: https://orcid.org/0000-0003-2276-9243)
Institutions
- Jagiellonian University (PL)
- Institute of Physiology and Pathology of Hearing (PL)
Publication Details
- Journal
- International Journal of Pediatric Otorhinolaryngology
- Published
- 2024-09-20
- DOI
- https://doi.org/10.1016/j.ijporl.2024.112113
- Primary Topic
- Asthma and respiratory diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00